Drug Testing Locations - Greeley, NE

Drug Testing in Greeley, NE

Greeley, Nebraska Statistics

In 2021, Greeley, located in Greeley County, saw a 10% increase in drug-related arrests.

Greeley County has reported that 15% of its DUI arrests in the last year involved drug impairment.

Emergency room visits related to drug overdoses in Greeley County rose by 8% over the previous year.

Greeley has reported a 12% hike in opioid prescriptions dispensed from 2019 to 2022.

Methamphetamine remains the most frequently seized illicit drug in Greeley County according to recent reports.

Youth drug use in Greeley, NE shows a 5% rise in high school students indicating they experimented with drugs.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Greeley, NE & Drug Testing Policies

Employers in Greeley, NE, recognize the implications of drug use in the workplace and have implemented strict drug testing policies. Many companies adhere to standards set by the U.S. Department of Labor, ensuring a safe work environment.

Local employers often conduct random drug screenings and promote employee assistance programs for those struggling with substance abuse. The adoption of these measures reflects a strong commitment to maintaining productivity and workplace safety.

For specific industry guidelines on drug testing, businesses can consult resources provided by the Occupational Safety and Health Administration, which offer detailed regulatory advice.

Government Efforts with Drug Problems in Greeley, NE

The government of Greeley, NE, is actively engaged in tackling drug problems through initiatives like increased funding for local health services and educational campaigns. More information can be accessed through the Nebraska Department of Health and Human Services.

Additionally, Greeley County collaborates with the state government in organizing workshops for drug education and prevention, targeting schools and communities. To know more about these initiatives, you can visit the Office of the Governor of Nebraska.

Local Drug Busts & News in Greeley, NE

In recent years, Greeley, NE, has experienced notable drug busts, highlighting the ongoing battle against narcotics distribution. Law enforcement agencies focus on curbing the flow of drugs through various intervention strategies.

For instance, collaborative efforts between Greeley County police and federal agencies led to the dismantling of several methamphetamine rings. Such operations are crucial in disrupting local and regional drug trafficking networks.

Community events organized in Greeley often aim to spread awareness and educate the public about the dangers associated with drug abuse, significantly contributing to preventative measures and rehabilitation.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Greeley, NE. Trusted by employers nationwide for accurate results and exceptional service.

Nebraska DOT/Non DOT Physicals

Nebraska Vision Tests

Nebraska Audiograms

Nebraska Respirator Fit Tests

Nebraska Lift Tests

Nebraska Background Checks

Clinical Testing Services

TB Testing in NE

Diabetes Testing in NE

Infectious Disease Testing in NE

Sickle Cell Anemia Testing in NE

Women/Men's Health Testing in NE

Resources & Citations

DrugRehab.com

SAMHSA National Helpline

Nebraska Drug Testing

Recovery.gov

Addiction Resource

Help.org

Narcotics Anonymous

AAP Publications

Hazelden Betty Ford Foundation

Alcohol and Drug Dependency

Drug Testing Near Greeley, NE

St. Paul, NE

Saint Paul, NE

Valley, NE

Bartlett, NE

Ord, NE

Cushing, NE

Elba, NE

Cedar Rapids, NE

Ericson, NE

Cotesfield, NE

Primrose, NE

Wolbach, NE

Scotia, NE

Spalding, NE

Greeley Center, NE

Frequently Asked Questions

Customer Reviews